Is Veru Stock a Buy Now?
Veru (NASDAQ: VERU) is a bit of an oddball in biotech. It's developing medicines for breast cancer and treatment-resistant prostate cancer, but it's also trialing a therapy for severe COVID-19, not to mention making a globally distributed reproductive health product.
And to top it all off, its share price is up by more than 1,000% in the last five years -- but much of that growth happened in the last week. With a gain like that, could Veru be a diamond in the rough? Not exactly. But, it's still a stock that should definitely be of interest to growth investors.
Image source: Getty Images.
Source Fool.com
